{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:48:37Z","timestamp":1792432117582,"version":"4.5.0"},"reference-count":44,"publisher":"Medknow","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.11622\/smedj.2019085","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T09:31:18Z","timestamp":1564479078000},"page":"419-425","source":"Crossref","is-referenced-by-count":8,"title":["Short- and long-term predictors of spontaneous bacterial peritonitis in Singapore"],"prefix":"10.4103","volume":"61","author":[{"given":"YJ","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RC","family":"Kalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KW","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EK","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JW","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TL","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","published-online":{"date-parts":[[2020,8]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez J","year":"2019","unstructured":"1. Fern\u00e1ndez J, Prado V, Trebicka J, et al; European Foundation for the Study of Chronic Liver Failure (EF-Clif). Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J Hepatol 2019; 70:398-411.","journal-title":"J Hepatol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","unstructured":"2. Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014; 60:1310-24.","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10620-018-4990-y","article-title":"Mortality from spontaneous bacterial peritonitis among hospitalized patients in the USA","volume":"63","author":"Niu","year":"2018","unstructured":"3. Niu B, Kim B, Limketkai BN, et al. Mortality from spontaneous bacterial peritonitis among hospitalized patients in the USA. Dig Dis Sci 2018; 63:1327-33.","journal-title":"Dig Dis Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized controlled clinical trial","volume":"63","author":"Piano","year":"2016","unstructured":"4. Piano S, Fasolato S, Salinas F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized controlled clinical trial. Hepatology 2016; 63:1299-309.","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jhep.2011.11.010","article-title":"Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis","volume":"56","author":"Ariza","year":"2012","unstructured":"5. Ariza X, Castellote J, Lora-Tamayo J, et al. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol 2012; 56:825-32.","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1365-2036.2012.05076.x","article-title":"Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study","volume":"35","author":"Reuken","year":"2012","unstructured":"6. Reuken PA, Pletz MW, Baier M, et al. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther 2012; 35:1199-208.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4254\/wjh.v7.i3.304","article-title":"Spontaneous bacterial peritonitis: the clinical challenge of a leaky gut and a cirrhotic liver","volume":"7","author":"Lutz","year":"2015","unstructured":"7. Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: the clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol 2015; 7:304-14.","journal-title":"World J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Arab JP, Martin-Mateos RM, Shah VH. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. Hepatol Int 2018; 12(Suppl 1):24-33.","DOI":"10.1007\/s12072-017-9798-x"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00042737-200204000-00006","article-title":"Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis","volume":"14","author":"Such","year":"2002","unstructured":"9. Such J, Guardiola JV, de Juan J, et al. Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur J Gastroenterol Hepatol 2002; 14:371-6.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref9","unstructured":"10. Xu WH, Wu XJ, Li JS. Influence of portal pressure change on intestinal permeability in patients with portal hypertension. Hepatobiliary Pancreat Dis Int 2002; 1:510-4."},{"key":"ref10","unstructured":"11. Pascual S, Such J, Esteban A, et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003; 50:1482-6."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/00365520510024278","article-title":"Intestinal permeability in cirrhotic patients with and without ascites","volume":"41","author":"Kalaitzakis","year":"2006","unstructured":"12. Kalaitzakis E, Johansson JE, Bjarnason I, Bj\u00f6rnsson E. Intestinal permeability in cirrhotic patients with and without ascites. Scand J Gastroenterol 2006; 41:326-30.","journal-title":"Scand J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","unstructured":"13. Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513:59-64.","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Macnaughtan J, Jalan R. Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis. Am J Gastroenterol 2015; 110:1399-410; quiz 1411.","DOI":"10.1038\/ajg.2015.313"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/0016-5085(86)90185-X","article-title":"Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis","volume":"91","author":"Runyon","year":"1986","unstructured":"15. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986; 91:1343-6.","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0016-5085(93)90284-J","article-title":"Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites","volume":"104","author":"Andreu","year":"1993","unstructured":"16. Andreu M, Sola R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993; 104:1133-8.","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/hep.1840160318","article-title":"Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration","volume":"16","author":"Llach","year":"1992","unstructured":"17. Llach J, Rimola A, Navasa M, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992; 16:724-7.","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. de Mattos AA, Costabeber AM, Lion\u00e7o LC, Tovo CV. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management? World J Gastroenterol 2014; 20:14079-86.","DOI":"10.3748\/wjg.v20.i39.14079"},{"key":"ref18","unstructured":"19. World Health Organization. Global action plan on antimicrobial resistance. Available at: http:\/\/www.who.int\/antimicrobial-resistance\/publications\/globalaction-plan\/en\/. Accessed January 3, 2019."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.3748\/wjg.v23.i25.4654","article-title":"Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: a systematic review","volume":"23","author":"Fiore","year":"2017","unstructured":"20. Fiore M, Maraolo AE, Gentile I, et al. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: a systematic review. World J Gastroenterol 2017; 23:4654-60.","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s12072-014-9543-7","article-title":"Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study","volume":"8","author":"Kim","year":"2014","unstructured":"21. Kim MJ, Song KH, Kim NH, et al. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study. Hepatol Int 2014; 8:582-7.","journal-title":"Hepatol Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/MEG.0000000000000700","article-title":"Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study","volume":"28","author":"Oliveira","year":"2016","unstructured":"22. Oliveira AM, Branco JC, Barosa R, et al. Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study. Eur J Gastroenterol Hepatol 2016; 28:1216-22.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/MEG.0000000000001111","article-title":"Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers","volume":"30","author":"Iliaz","year":"2018","unstructured":"23. Iliaz R, Ozpolat T, Baran B et al. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers. Eur J Gastroenterol Hepatol 2018; 30:786-91.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","unstructured":"24. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341:403-9.","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"46025","DOI":"10.1038\/srep46025","article-title":"Nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis in China: comparative microbiology and therapeutic implications","volume":"7","author":"Shi","year":"2017","unstructured":"25. Shi L, Wu D, Wei L, et al. Nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis in China: comparative microbiology and therapeutic implications. Sci Rep 2017; 7:46025.","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","unstructured":"26. Moreau R, Jalan R, Gines P, et al; CANONIC Study Investigators of the EASL-CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144:1426-37.","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11901-019-00447-3","article-title":"A review","volume":"18","author":"Sanchez","year":"2019","unstructured":"27. Sanchez LO, Gustot T. Multidrug-resistant bacterial infection in patients with cirrhosis. A review. Curr Hepatology Rep 2019; 18:28-35.","journal-title":"Curr Hepatology Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1086\/597585","article-title":"Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis","volume":"48","author":"Cheong","year":"2009","unstructured":"28. Cheong HS, Kang CI, Lee JA, et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 2009; 48:1230-6.","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3346\/jkms.2006.21.4.666","article-title":"Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired","volume":"21","author":"Song","year":"2006","unstructured":"29. Song JY, Jung SJ, Park CW, et al. Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired. J Korean Med Sci 2006; 21:666-71.","journal-title":"J Korean Med Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.cgh.2012.08.017","article-title":"High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center","volume":"10","author":"Tandon","year":"2012","unstructured":"30. Tandon P, Delisle A, Topal JE, Garcia-Tsao G. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol 2012; 10:1291-8.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"10409","DOI":"10.3748\/wjg.v21.i36.10409","article-title":"Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients","volume":"21","author":"YT","year":"2015","unstructured":"31. Li YT, Yu CB, Huang JR, Qin ZJ, Li LJ. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients. World J Gastroenterol 2015; 21:10409-17.","journal-title":"World J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/340617","article-title":"Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection","volume":"35","author":"Campillo","year":"2002","unstructured":"32. Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 2002; 35:1-10.","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3748\/wjg.v22.i15.4049","article-title":"Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia","volume":"22","author":"Alexopoulou","year":"2016","unstructured":"33. Alexopoulou A, Vasilieva L, Agiasotelli D, et al. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. World J Gastroenterol 2016; 22:4049-56.","journal-title":"World J Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.4254\/wjh.v9.i30.1166","article-title":"Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis","volume":"9","author":"Fiore","year":"2017","unstructured":"34. Fiore M, Maraolo AE, Gentile I, et al. Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. World J Hepatol 2017; 9:1166-75.","journal-title":"World J Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. \u00d6zdo\u011fan OC. Empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: should we start direct broader-spectrum antibiotics or not? Turk J Gastroenterol 2016; 27:294-5.","DOI":"10.5152\/tjg.2016.160001"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69:406-60.","DOI":"10.1016\/j.jhep.2018.08.009"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s15010-008-8060-9","article-title":"Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis","volume":"37","author":"Umgelter","year":"2009","unstructured":"37. Umgelter A, Reindl W, Miedaner M, Schmid RM, Huber W. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection 2009; 37:2-8.","journal-title":"Infection"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2334-9-41","article-title":"Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study","volume":"9","author":"Song","year":"2009","unstructured":"38. Song KH, Jeon JH, Park WB, et al. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis 2009; 9:41.","journal-title":"BMC Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3904\/kjim.2017.231","article-title":"Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis","volume":"35","author":"Kim","year":"2020","unstructured":"39. Kim J, Kang CI, Gwak GY, et al. Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis. Korean J Intern Med 2020; 35:215-21.","journal-title":"Korean J Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3350\/cmh.2013.19.2.131","article-title":"Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis","volume":"19","author":"Tsung","year":"2013","unstructured":"40. Tsung PC, Ryu SH, Cha IH, et al. Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis. Clin Mol Hepatol 2013; 19:131-9.","journal-title":"Clin Mol Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Mandorfer M, Bota S, Schwabl P, et al. Nonselective b blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 2014; 146:1680-90.e1.","DOI":"10.1053\/j.gastro.2014.03.005"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/liv.13119","article-title":"Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers","volume":"36","author":"Bang","year":"2016","unstructured":"42. Bang UC, Benfield T, Hyldstrup L, Jensen JE, Bendtsen F. Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers. Liver Int 2016; 36:1304-12.","journal-title":"Liver Int"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"RP","year":"2016","unstructured":"43. Mookerjee RP, Pavesi M, Thomsen KL, et al; CANONIC Study Investigators of the EASL-CLIF Consortium. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol 2016; 64:574-82.","journal-title":"J Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jhep.2016.01.031","article-title":"Keep the sick from harm in spontaneous bacterial peritonitis: dose of beta blockers matters","volume":"64","author":"Madsen","year":"2016","unstructured":"44. Madsen BS, Nielsen KF, Fialla AD, Krag A. Keep the sick from harm in spontaneous bacterial peritonitis: dose of beta blockers matters. J Hepatol 2016; 64:1455-6.","journal-title":"J Hepatol"}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/short-and-long-term-predictors-spontaneous-bacterial-peritonitis-singapore","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:52:03Z","timestamp":1660042323000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/short-and-long-term-predictors-spontaneous-bacterial-peritonitis-singapore"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]},"published-print":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2019085","relation":{},"ISSN":["0037-5675"],"issn-type":[{"value":"0037-5675","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}